R1 Therapeutics
Latest round
- Series A
Last raised
- Sep 2026
Total raised
- $81M
Investors
- 7
About R1 Therapeutics
R1 Therapeutics Ltd specializes in the development of therapies for kidney disease.S. Renal Care, Inc.R1 Therapeutics specializes in developing innovative therapies for patients with kidney disease, primarily focused on hyperphosphatemia associated with chronic kidney disease (CKD). The company's lead product, AP306, is a first-in-class pan phosphate transporter inhibitor designed to block the active transport of phosphate in the gastrointestinal tract, targeting three key transporters: NaPi-IIb, PiT-1, and PiT-2. This mechanism aims to provide rapid phosphate lowering while reducing treatment burden for patients who rely on traditional phosphate binders.R1 Therapeutics operates in the biotechnology sector, particularly within the renal therapeutics market. The revenue model relies on partnerships with healthcare providers and pharmaceutical collaborations, including licensing agreements for AP306. As a prescription medication, AP306 is expected to be marketed to hospitals, dialysis centers, and specialty pharmacies serving CKD patients.
Who invested in R1 Therapeutics
7 investors across 2 rounds
See all investors in R1 Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about R1 Therapeutics
Who invested in R1 Therapeutics?
R1 Therapeutics has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has R1 Therapeutics raised?
R1 Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did R1 Therapeutics last raise money?
R1 Therapeutics's most recent round on record is a Series A, in Sep 2026.
What does R1 Therapeutics do?
R1 Therapeutics Ltd specializes in the development of therapies for kidney disease.
Where is R1 Therapeutics headquartered?
R1 Therapeutics is headquartered in San Francisco, US.
Which VCs invest in companies like R1 Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at R1 Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like R1 Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.